Wouldn't a combo trial with Gilead get us much needed exposure?

It seems that would spike our share price, more importantly it would make people look deeper into Cytodyn and our drug Vyrologix. When that happens, the difference between Vyrologix and Remdesivir becomes apparent and the unquestionable superiority of Vyrologix.

I would love a partnership like that.

Just my thought, what am I missing?